Kenneth Grossmann

3PUBLICATIONS

48CO-AUTHORS

Predictive and prognostic markersInnate immunityHaematological tumours

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Jun 23, 2026

Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 Therapy.

|Apr 08, 2024

Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity.

Isabella C Glitza, Yongwoo David Seo, Christine N Spencer

|Nov 12, 2021

Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma.

Kenneth F Grossmann, Megan Othus, Sapna P Patel

Pageof 1

Frequent Collaborators

2 joint publications

Sapna P Patel

2 joint publications

Vernon K Sondak

2 joint publications

Kari Kendra

2 joint publications

Elad Sharon

2 joint publications

John M Kirkwood

2 joint publications

Antoni Ribas

1 joint publications

Ahmad A Tarhini

1 joint publications

Pauline Funchain

1 joint publications

Bartosz Chmielowski

1 joint publications

Nageatte Ibrahim

Frequent Collaborators

2 joint publications

Sapna P Patel

2 joint publications

Vernon K Sondak

2 joint publications

Kari Kendra

2 joint publications

Elad Sharon